Medical News

RSS

New tool to predict epidemics of malaria up to five months in advance

The model uses predictions of climate variability to indicate the level of risk of an epidemic up to five months in advance of the peak malaria season - the earliest point at which predictions have ever been made.

7 Feb 2006

Biochemists detect subtle new gyration that protein molecules undergo

Biochemists have detected a surprising, subtle new gyration that protein molecules undergo in the intricate, squirming dance that influences their activity in the cell.

7 Feb 2006

Many women who are eligible for rubella vaccination are not being immunized after giving birth

Contrary to federal recommendations, many women who are eligible for rubella vaccination are not being immunized after giving birth, a new study of Miami-area hospitals has found.

7 Feb 2006

French may be headed for similar obesity and heart problems as U.S.

Just 2 pounds of weight gain can greatly increase a person's risk for the metabolic syndrome, a dangerous condition that can lead to type 2 diabetes and coronary heart disease, finds a Kaiser Permanente study.

7 Feb 2006

Women more sensitive to pain during periods of low estrogen

Now researchers are going one step further by studying whether the difference in pain sensitivity is reflected in brain activity as measured by functional magnetic resonance imaging (fMRI).

7 Feb 2006

New report on asbestos litigation trend

The American Academy of Actuaries' Mass Torts Subcommittee have released a report, Current Issues in Asbestos Litigation, examining recent trends in asbestos litigation. Included is a brief overview of asbestos litigation and highlights of recent changes in the litigation environment.

7 Feb 2006

Sanofi pasteur delivers more H5N1 vaccines to U.S. Government

Sanofi pasteur has delivered more H5N1 vaccine to the U.S. government including investigational doses formulated with an adjuvant.

7 Feb 2006

New technology for accelerating development of vaccines against H5N1 flu

Technology that enables scientists to identify targets for the development of vaccines against viruses such as H5N1 in weeks rather than months has entered a pilot study at ProImmune, Oxford, UK.

7 Feb 2006

Chromium helps muscles become more efficient

Researchers found that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats

7 Feb 2006

Almost two-thirds of California children have dental disease

A study released today by the Dental Health Foundation found that by third grade, almost two-thirds of California children have dental disease, making it the most prevalent children's health problem in the state.

7 Feb 2006

Advocacy groups unite to make lung cancer in women a top priority

Women's health and lung cancer advocacy groups, led by the Society for Women's Health Research, vowed today to make lung cancer education and advocacy, especially among women, a top priority for their organizations in 2006 and beyond.

7 Feb 2006

FDA grants fast track status for ViroPharma's Maribavir

ViroPharma Incorporated has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation for maribavir, an oral antiviral drug candidate for the prevention of cytomegalovirus (CMV) infection in allogeneic bone marrow (stem cell) and solid organ transplant patients.

7 Feb 2006

Microbia and DuPont collaborate to develop novel biomanufacturing process

Microbia, Inc. has announced the formation of a collaborative research and development program between DuPont Central Research & Development (CR&D) and Microbia's Precision Engineering business unit.

7 Feb 2006

Genesis bioventures announces worldwide distribution rights for rapid prion-detection technology

Genesis Bioventures, Inc. has announced that the Company has signed exclusive worldwide sales, marketing and distribution agreements with Prion Developmental Laboratories Inc. (PDL) to commercialize the recently patented Rapid Prion-Detection Assay tests developed by PDL.

7 Feb 2006

Viragen reports on Multiferon anti-viral studies

Viragen, Inc today reported on the progression of anti-viral studies using Multiferon (multi-subtype, natural human alpha interferon) being conducted by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID).

7 Feb 2006

Oncolytics Biotech granted new patent

Oncolytics Biotech Inc. has been granted U.S. Patent 6,994,858 entitled "Reovirus Clearance of Ras-Mediated Neoplastic Cells from Mixed Cellular Compositions."

7 Feb 2006

Bristol-Myers Squibb and Otsuka Pharmaceutical announce availability of 2 mg Abilify (aripiprazole) tablet

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced two newly available options of Abilify (aripiprazole) -- a 2 mg tablet strength and a nonrefrigerated oral solution (1 mg/mL).

7 Feb 2006

Molecular Devices introduces a high-speed, laser-scanning, confocal imager

This system is the latest addition to its Total Imaging Solution which includes the ImageXpressMICRO imaging system, MetaXpress Software Application Modules, AcuityXpress Data Analysis software and the Transfluor Assay for GPCRs.

7 Feb 2006

Monotherapy phase I clinical trials of novel cytotoxics, targeted therapeutics, antimetastatic agents/angiogenesis inhibitors, and immunotherapeutics/vaccines

Numerous novel oncology agents are currently in phase I monotherapy trials. New Medicine's Oncology KnowledgeBASE (nm|OK) has updated the records of 92 such agents with preclinical or clinical results reported during the 2005 meetings of the American Association for Cancer Research (AACR)

7 Feb 2006

Biosense Webster receives FDA approval for technology to treat heart rhythm disease

The U.S. Food and Drug Administration (FDA) today approved an innovative combination of technologies that will enhance a doctors' ability to treat patients with abnormal heart rhythms (cardiac arrhythmias).

7 Feb 2006